Related Experiment Videos
Positive findings on bone scan in multiple myeloma
N J Murthy1, H Rao, A S Friedman
1Department of Medicine, Coney Island Hospital, Brooklyn, NY 11223, USA.
Southern Medical Journal
|January 9, 2001
Summary
Bone scans using technetium Tc 99m methylene diphosphonate show high uptake in multiple myeloma bone lesions. Bone scintigraphy is more sensitive than radiography for detecting myeloma-related osteolytic lesions in the ribs, scapula, and spine.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Multiple myeloma frequently causes osteolytic bone lesions.
- Conventional skeletal radiography is standard for detecting these lesions.
- The role of bone scintigraphy in multiple myeloma diagnosis is debated.
Purpose of the Study:
- To evaluate the utility of bone scintigraphy in diagnosing multiple myeloma bone lesions.
- To compare the sensitivity of bone scans versus radiography for detecting osteolytic lesions.
Main Methods:
- Case report of multiple myeloma with high technetium Tc 99m methylene diphosphonate uptake in bone lesions.
- Literature review comparing conventional radiography and bone scans for myeloma-related osteolytic lesions.
Main Results:
- Bone scintigraphy demonstrated high uptake in the reported myeloma bone lesions.
- Literature review indicates bone scintigraphy is more sensitive than radiography for detecting lesions in the ribs, scapula, and spine.
- Many clinicians underestimate the role of bone scintigraphy in myeloma detection.
Conclusions:
- Bone scintigraphy is a sensitive tool for detecting multiple myeloma osteolytic bone lesions.
- Nuclear medicine imaging, specifically bone scans, should be considered in the diagnostic workup of multiple myeloma.
- Radiologists and oncologists should be aware of the enhanced sensitivity of bone scintigraphy in specific skeletal regions.